000 | 01448 a2200409 4500 | ||
---|---|---|---|
005 | 20250512232924.0 | ||
264 | 0 | _c19811029 | |
008 | 198110s 0 0 eng d | ||
022 | _a0091-6749 | ||
024 | 7 |
_a10.1016/0091-6749(81)90181-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSheffer, A L | |
245 | 0 | 0 |
_aClinical and biochemical effects of stanozolol therapy for hereditary angioedema. _h[electronic resource] |
260 |
_bThe Journal of allergy and clinical immunology _cSep 1981 |
||
300 |
_a181-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAndrogens _xpharmacology |
650 | 0 | 4 |
_aAngioedema _xdrug therapy |
650 | 0 | 4 | _aComplement C1 Inactivator Proteins |
650 | 0 | 4 |
_aCreatine Kinase _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMenstruation Disturbances _xetiology |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOxymetholone _xtherapeutic use |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aStanozolol _xadverse effects |
650 | 0 | 4 |
_aThyroxine-Binding Proteins _xblood |
700 | 1 | _aFearon, D T | |
700 | 1 | _aAusten, K F | |
773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 68 _gno. 3 _gp. 181-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0091-6749(81)90181-0 _zAvailable from publisher's website |
999 |
_c6790350 _d6790350 |